VAM
BMY icon

Vienna Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Vienna Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,150
Closed -$134K – 87
2021
Q4 		$134K Buy
+2,150
New +$126K 0.12% 80

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vienna Asset Management's BMY Position: Q1 2022 in Review

Vienna Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 2,150 shares — an estimated $134K sold.

Vienna Asset Management first reported a position in BMY in Q4 2021 and held it in 1 quarter. The position peaked at $134K in Q4 2021. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

  • Vienna Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
  • Vienna Asset Management sold 2,150 Bristol-Myers Squibb shares in Q1 2022, an estimated $134K.
  • Vienna Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 1 quarter.
  • Vienna Asset Management's Bristol-Myers Squibb position peaked at $134K in Q4 2021.
  • 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Vienna Asset Management's 13F filing for Q1 2022, filed 16 May 2022.